Topically Applied Recombinant Chemokine Analogues Fully Protect Macaques from Vaginal Simian‐Human Immunodeficiency Virus Challenge
Open Access
- 15 May 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 199 (10) , 1525-1527
- https://doi.org/10.1086/598685
Abstract
Effective strategies for preventing human immunodeficiency virus infection are urgently needed, but recent failures in key clinical trials of vaccineKeywords
This publication has 16 references indexed in Scilit:
- Chemokine Analogues Show Suitable Stability for Development as MicrobicidesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- AIDS gel's failure calls prevention approach into questionNature Medicine, 2007
- Biology of CCR5 and Its Role in HIV Infection and TreatmentJAMA, 2006
- Microbicides and other topical strategies to prevent vaginal transmission of HIVNature Reviews Immunology, 2006
- Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus–cell fusionNature, 2005
- Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDSJournal of Medical Primatology, 2005
- Topical Microbicides Become TopicalNew England Journal of Medicine, 2005
- Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitorsProceedings of the National Academy of Sciences, 2004
- Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5Science, 2004
- Noninvasive Detection of New Simian Immunodeficiency Virus Lineages in Captive Sooty Mangabeys: Ability To Amplify Virion RNA from Fecal Samples Correlates with Viral Load in PlasmaJournal of Virology, 2003